Skip to main content
logo
Y-Biologics, Inc. (KOSDAQ:338840)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,880.00
+490.00 (5.22%)
At close: Aug 20, 2026

Y-Biologics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
151,823347,578113,678230,299--
Market Cap Growth
-8.42%205.76%-50.64%---
Enterprise Value
126,282324,452102,035230,749--
Last Close Price
9880.0022900.007690.0015600.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
54.46119.3219.7366.19--
PB Ratio
6.7713.075.798.86--
P/TBV Ratio
6.9213.336.279.94--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
45.30111.3817.7166.33--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.700.560.040.110.250.21
Net Debt / Equity Ratio
-1.14-1.11-0.58-0.69-0.40-0.39
Net Debt / EBITDA Ratio
2.864.021.782.310.510.73
Net Debt / FCF Ratio
3.184.301.632.310.720.66
Asset Turnover
0.080.080.220.120.120.11
Quick Ratio
16.0835.9310.587.391.602.91
Current Ratio
16.4536.1610.737.481.703.20
Return on Equity (ROE)
-221.97%-181.79%-28.23%-90.84%-77.73%-54.50%
Return on Assets (ROA)
-18.45%-14.95%-20.30%-21.27%-34.84%-24.67%
Return on Capital Employed (ROCE)
-21.20%-17.00%-41.10%-37.00%-90.60%-54.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-29.28%-12.09%-5.67%-9.06%--
FCF Yield
-5.29%-1.98%-6.16%-3.39%--
Buyback Yield / Dilution
-1.33%-0.80%-18.01%-1.87%-1.01%-21.93%